ABSTRACT
INTRODUCTION
A high-quality colonoscopy that ensures the detection and removal of all neoplastic lesions is key for the efficacy of screening and surveillance of colorectal cancer (CRC) (1, 2) . Unfortunately, up to 20% of all neoplastic lesions, especially small and flat lesions, are still missed during a colonoscopy (3) (4) (5) . This unsatisfactorily high overall miss rate remains a concern and is one of the key factors in the development of interval cancer (6) . Many common reasons for missing lesions are related to a number of elements of procedural quality such as bowel preparation (7, 8) , but they also partly result from the highly operator-dependent nature of the procedure (9) . In fact, the quality of a colonoscopy as measured by the adenoma detection rate (ADR), which is an independent predictor of the risk of interval cancer, varies widely among physicians (9) (10) (11) (12) . Detection of flat, subtle lesions in the colon, including serrated adenomas/polyps, remains a challenge depending on a careful operator technique. Appropriate endoscopist performance characteristics with meticulous inspection and an adequate withdrawal time increase colonoscopy yield, reducing the substantial miss rate reported with standard resolution white light colonoscopies (SRWL) (13, 14) .
However, missing non-polypoid or flat lesions that often evade detection with SRWL might be a factor for colonoscopy failure as well (15) . Importantly, these flat adenomas may carry a higher risk of developing into CRCs than polypoid adenomas (5, 16, 17) .
During the last two decades, a number of advances have been made to overcome the limitations of standard white light and traditional forward-viewing angle colonoscopies in recognizing flat lesions. Among these advances, the higher resolution provided by high definition (HD) scopes coupled with chromoscopy provides a more detailed imaging of the colonic mucosa and might improve the detection of these subtle lesions that would otherwise be overlooked by an SRWL colonoscopy. However, despite these potential benefits, this technique has shown a moderate gain (18, 19) , and its role in average-risk patients undergoing routine screening has not been fully established. The HD+i-SCAN (Pentax, Japan) method is a post processing image technique that enhances the contrast of the image using computerized spectral estimation technology that selects specific light wavelengths. The HD+i-SCAN technique has not been as widely implemented as narrow band imaging, and less evidence is available for evaluation of this application of the technique.
The aim of the present study was to determine whether the use of a HD+i-SCAN colonoscopy improves diagnostic performance of a colonoscopy compared to the use of a SRWL colonoscopy with respect to ADR, adenoma per colonoscopy (APC) and flat ADR (FADR) in an average risk population undergoing a comprehensive CRC screening colonoscopy.
METHODS
This is a retrospective analysis of a prospectively collected screening colonoscopy database.
The data from consecutive asymptomatic outpatients without any familial CRC background who were 50 years of age or older and undergoing their first CRC screening colonoscopy in the Hospital General de Catalunya were analyzed. A comparative performance analysis of HD+i-SCAN (90i series, Pentax, Tokyo, Japan) versus SRWL (EC-3870FZK, Pentax) colonoscopies was performed. Assignment to conventional endoscopy or HD+i-SCAN was determined only by the availability of high-definition or conventional endoscope at the time of exploration.
Only patients with excellent or good preparations and cecal intubation were included. All comprehensive standardized colonoscopies were performed by two experienced endoscopists (A.R.; E.S). Withdrawal times were targeted to exceed at least 6 minutes in all colonoscopies. All withdrawal times were recorded and they were defined as the amount of time spent examining the colon (without taking into account polypectomy or biopsy times) during withdrawal of the colonoscope. Time recording began after cecal intubation ("time Zero"). Cecal intubation was defined as the ability to touch the cecal pole with the tip of the colonoscope.
Patients were excluded if they had previous surgery of the colon, known inflammatory bowel disease, acute gastrointestinal bleeding, a genetic-associated colon cancer risk or impaired coagulation parameters (international normalized ratio [INR] > 1.74, partial thromboplastin time [PTT] > 50 seconds).
Prior to colonoscopy, patients were prepared using one of two standard preparations: MoviPrep (polyethylene glycol 3,350 and additives) (Norgine de España, S.L.U. Madrid, Spain) or two sachets of Citrafleet (sodium picosulfate) (Casen Recordati, S.L., Zaragoza, Spain). All patients received written instructions for the colonoscopy preparation method used. All colonoscopy procedures were performed under deep sedation with propofol, which was administered by the assistant or attending anesthetist.
The preparation grade was measured by the previously validated Aronchick scale (i.e., excellent, good, fair, poor, and unsatisfactory) (20) .
A detailed examination of the colon was started when the cecum was reached, and the surface enhancement function was activated throughout the withdrawal of the instrument. The i-scan mode has been previously described elsewhere (21) . Physicians were allowed to switch between HD imaging alone and the i-scan mode as pleased. Identified lesions in the HD+i-SCAN group were further characterized using the p-and v-modes (21) .
Detected colorectal lesions were characterized according to the Paris Classification system (22) . Resections were performed on all identified lesions. Location, size and pathology results were recorded. The term "flat adenoma" was only used if the adenoma lesion was either slightly elevated (0-IIa) or completely flat (0-IIb) (absolutely depressed lesions were not included in this definition) compared to the adjacent mucosa.
The data were classified according to numbers of polyps and adenomas, adenomas proximal to the splenic flexure (proximal adenomas), and advanced adenomas (i.e., > 1 cm in size, villous, or containing high-grade dysplasia or cancer). Detection rates were calculated for polyps (PDR), adenomas (ADR), flat adenomas (FADR) and proximal adenomas (PADR). Additionally, the number of adenomas (APC) and serrated adenomas (SAPC) per colonoscopy were also calculated.
As a retrospective evaluation, this study did not require ethics committee approval.
Statistical analysis
Continuous variables were expressed as the mean and standard deviation (SD). Categorical variables were summarized as frequency and percentage. The 95% confidence interval (CI) was calculated using the standard formula. Predictive factors for the detection rates were analyzed by univariate analysis using a Chi-square test for categorical variables and a t-test for continuous variables. A p va lue less than 0.05 was considered to be statistically significant. All calculations were performed using SPSS statistical software version 20.0 (IBM SPSS INC, Chicago).
RESULTS
From January 2013 to March 2015, 163 consecutive screening colonoscopies were performed in the general population; 155 (95.1%) patients met the inclusion criteria (Fig. 1) . Sixty of 155 (39%) colonoscopies were performed using a HD+i-SCAN colonoscope, and the remaining 95 (61%) were performed using a SRWL colonoscope. Both groups were similar in terms of age (56.9 and 57 years old in the HD+i-SCAN group and SRWL group, respectively), gender (41.5% and 48.4% males ratio, respectively, for each group), BMI, alcohol use, aspirin use and cigarette use (Table I) . Both endoscopists used both types of colonoscopes, and no significant differences were found between the performances of the two endoscopists. Withdrawal times for both groups were also similar (HD+i-SCAN = 8.8 min vs. SRWL group = 8.4)
The overall number of lesions revealed was 230, with a total of 88 adenomatous polyps in 155 patients. The global ADRs were 36.6% for male patients (95% CI: 27%-47.4%) and 21.9% for female patients (95% CI: 13.9-32.8%) (p < .05). There were no significant differences between ADR or APC for procedures performed with the HD+i-SCAN and SRWL colonoscopes (Fig. 2) . A larger proportion of patients were found to have at least three adenomas in the HD+i-SCAN group than in the SRWL group (11.6% vs. 4.4%), although this difference did not reach statistical significance.
DISCUSSION
The usefulness of an HD+i-SCAN colonoscope for screening colonoscopies remains controversial. Our study found that the HD+i-SCAN revealed more non-polypoid adenomas than the SRWL in a series of 155 consecutive average-risk patients undergoing a screening colonoscopy. FADR was significantly higher with the HD+i-SCAN colonoscope than with the SRWL colonoscope, whereas there was no significant difference between the overall ADR detected by both imaging techniques. Although our findings should be interpreted cautiously, our results provide evidence that the higher resolution and surface mucosal contrast provided by HD+i-SCAN helped endoscopists to detect subtle lesions that might not have been detected by an SRWL endoscope. The lack of difference regarding ADR between the two colonoscopes is likely explained, at least in part, by the fact that the HD+i-SCAN colonoscope is not expected to improve the detection of polypoid lesions that can be easily identified without enhanced resolution and contrast. It is also possible that the good ADR for all adenomas in our "control" SRWL group as a consequence of the excellent bowel preparation and comprehensive examination might have limited any additional improvement in the yield with the use of the HD+i-SCAN method. Finally, the relatively small number of procedures used to determine the ADR might not have been sufficient to ascertain statistical significance.
ADR is an accepted surrogate marker for the quality of a screening colonoscopy. However, measurement of ADR alone might not reliably assess the quality of a colonoscopy because it does not take into account other important determinants of interval cancer risk such as size, location or pathology of the removed lesions. It is possible that other indicators such as FADR, PADR, APC or advanced adenoma detection rate together with ADR could be a better method to determine the quality of the endoscopist performance in a screening colonoscopy (11, 23, 24) . Our results can be compared with those of previous randomized controlled trials that have compared chromoscopy with a SRWL colonoscope in terms of detection of colorectal adenomas. Our findings are fully consistent with those of Le Rhun et al. (25) , who found that although a high-definition colonoscopy with chromoscopy (indigo) increased the detection of flat adenomas compared to a standard definition colonoscopy, the overall ADR was not significantly improved in a population at increased risk for colonic neoplasia. In contrast, a Cochrane database systematic review reports that chromoscopy with indigo carmine is likely to yield significantly more patients with at least one neoplastic lesion (OR 1.67 [CI 1.29-2.15]) and significantly more patients with three or more neoplastic lesions (OR 2.5 [CI 1.5-4.4]) (26) . However, it is important to quote that, currently, digital chromoendoscopy (such as i-SCAN, NBI and FICE) has not shown in any metaanalysis to be superior to SRWL for detection of adenomas, so both techniques (digital chromoendoscopy vs. dye chromoendoscopy) could have different detection yield.
Our finding that HD+i-SCAN technology identified more flat polyps than the SRWL technique is consistent with those of one previous prospective randomized controlled trial (21) and that of one retrospective study of a large cohort of consecutive outpatients undergoing screening, diagnostic and surveillance colonoscopies (27) . Recently, Kim et al. have published similar results in a comparative study exclusively in average risk patients for CRC as in our study (28) .
Our study differs from these reports in several important aspects. In contrast to previous studies, we excluded the influence of bowel preparation and patients' baseline characteristics and compared the efficacy of HD+i-SCAN with that of SRWL colonoscopies according to lesion size, location and histology.
Our study has several strengths. First, the study was performed on a highly selected group of asymptomatic average-risk patients undergoing their first screening colonoscopy using current clinical practices. The distribution of gender, smoking or alcohol habits, and aspirin use was similar in both groups. Second, all patients were examined under optimal comprehensive conditions. All procedures were performed by experienced endoscopists, and comprehensive technique with a standardized withdrawal time was used. Only patients with excellent or good bowel preparations using a split dose bowel preparation and those in which the cecum was intubated and the entire length of the colon was screened were included. We standardized examination times to exceed at least 6 minutes in all colonoscopies, which minimized the impact of detection bias because a longer examination time would lead to a higher ADR.
Third, our ADRs were higher than those of previous studies and surpassed the proposed US Multi-Society Task Force on Colorectal Cancer threshold targets for populations undergoing a screening colonoscopy (29) . Additionally, the ADR of each participating endoscopist was similar; therefore, data could be compared as a whole. Our study also analyzed the flat ADR, APC, and PADR, which have not been reported in other previous studies.
Our study has several limitations that should be addressed. First, it is a retrospective, not randomized, single-center study. Second, it involved a small number of experienced endoscopists and might therefore not reflect the true diagnostic yield when performed in the conditions of routine practice. In addition, endoscopists could not be blinded to the techniques being used, which may have induced an unintentional bias towards one of the two techniques. However, the fact that the HD+i-SCAN colonoscope revealed more flat ADRs than the SRWL endoscope using a comparable colonoscopy technique and withdrawal time suggests that the increased diagnostic yield is, in fact, a result of technical improvement. Although there is some evidence suggesting that both HD and i-scan contribute to improved adenoma detection, the design of our study does not allow delineating the relative benefit provided by each one of the image enhancing components of the HD+i-SCAN system.
Finally, it is also important to note that, according to most current guidelines, with the use of an HD+i-SCAN colonoscope, in our study, a higher proportion of patients (although not statistically significant) would be classified as having high-risk-adenoma, in which the recommended post-polypectomy surveillance interval for an effective prevention of CRC is shortened to 3 years (30, 31) (Table II and Fig. 2) .
Lesions can also evade detection due to their location on the proximal hidden side of the haustral folds and flexures. It has been estimated that 10% of the colonic surface remains unobserved by the standard forward-viewing colonoscope even with a good bowel preparation. This is due to the limitation of the torquing and turning capabilities of the flexible bending portion of standard colonoscopes. We assume that the HD+i-SCAN colonoscope will not help to inspect the blind mucosa and therefore will not have any impact on the detection of missed lesions on the reverse side of the mucosal folds. Other recently developed ancillary techniques that may assist in detecting hidden lesions in the blind mucosal surface, such as cap-assisted, Endocuff, EndoRing, and balloon colonoscopies, work on the principle of flattening the haustral folds during withdrawal and, therefore, expanding the surface area of the colonic mucosa being visualized; the Third Eye Retroscope retrograde-viewing auxiliary device, or wider angle colonoscopes can be useful adjuncts (32) (33) (34) (35) (36) . In conclusion, our study found that the use of a HD+i-SCAN colonoscope yielded an increase in flat ADR compared to a SRWL colonoscope in average-risk CRC screening colonoscopies. HD+i-SCAN is a simple, quick and widely available technique that can be helpful, even for experienced providers, in detecting more subtle lesions in the right-side colon. The performance of HD+i-SCAN and the substantial prevalence of flat lesions in our average-risk screening cohort support its usefulness in improving efficacy of screening colonoscopies. 
